Teva North America recalls Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada Limited
Recalled August 31, 2016 · FDA recall D-1470-2016 · Teva North America
Hazard
Superpotent drug: Out of specification test result for assay during stability testing. · FDA Class II
Units
53,328 bottles
Sold at
Nationwide
Description
Superpotent drug: Out of specification test result for assay during stability testing.
Product
Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada Limited, Toronto, Canada, NDC 0093-4161-76
Manufacturer(s)
Teva North America
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →